GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oxford Nanopore Technologies PLC (OTCPK:ONTTF) » Definitions » Intangible Assets

Oxford Nanopore Technologies (Oxford Nanopore Technologies) Intangible Assets : $41.7 Mil (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Oxford Nanopore Technologies Intangible Assets?

Intangible assets are defined as identifiable non-monetary assets that cannot be seen, touched or physically measured. Oxford Nanopore Technologies's intangible assets for the quarter that ended in Dec. 2023 was $41.7 Mil.


Oxford Nanopore Technologies Intangible Assets Historical Data

The historical data trend for Oxford Nanopore Technologies's Intangible Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oxford Nanopore Technologies Intangible Assets Chart

Oxford Nanopore Technologies Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Intangible Assets
Get a 7-Day Free Trial 21.65 30.74 30.59 36.59 41.66

Oxford Nanopore Technologies Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Intangible Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only 30.59 30.91 36.59 38.20 41.66

Oxford Nanopore Technologies Intangible Assets Calculation

Intangible assets are defined as identifiable non-monetary assets that cannot be seen, touched or physically measured. Examples of intangible assets include trade secrets, copyrights, patents, trademarks. If a company acquires assets at the prices above the book value, it may carry goodwill on its balance sheet. Goodwill reflects the difference between the price the company paid and the book value of the assets.


Oxford Nanopore Technologies  (OTCPK:ONTTF) Intangible Assets Explanation

If a company (company A) received a patent through their own work, though it has value, it does not show up on its balance sheet as an intangible asset. However, if company A sells this patent to company B, it will show up on company B's balance sheet as an intangible asset.

The same applies to brand names, trade secrets etc. For instance, Coca-Cola's brand is extremely valuable, but the brand does not appear on its balance sheet, because the brand was never acquired.

Some intangibles are amortized. Amortization is the depreciation of intangible assets.

Many intangibles are not amortized. They may still be written down when the company decides the asset is impaired.

Whenever you see an increase in goodwill over a number of years, you can assume it's because the company is out buying other businesses above book value. GOOD if buying businesses with durable competitive advantage.

If goodwill stays the same, the company when acquiring other companies is either paying less than book value or not acquiring. Businesses with moats never sell for less than book value.

Intangibles acquired are on balance sheet at fair value.

Internally developed brand names (Coke, Wrigleys, Band-Aid) however are not reflected on the balance sheet.

One of the reasons competitive advantage power can remain hidden for so long.


Be Aware

Companies may change the way intangible assets are amortized, and this will affect their reported earnings.


Oxford Nanopore Technologies Intangible Assets Related Terms

Thank you for viewing the detailed overview of Oxford Nanopore Technologies's Intangible Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Oxford Nanopore Technologies (Oxford Nanopore Technologies) Business Description

Traded in Other Exchanges
Address
Edmund Halley Road, Gosling Building, Oxford Science Park, Oxford, Oxfordshire, GBR, OX44DQ
Oxford Nanopore Technologies PLC makes a novel generation of DNA/RNA sequencing technology that provides rich data and is fast, accessible, and easy to use. The Group is primarily involved in researching, developing, manufacturing, and commercializing the world's only commercial nanopore-based sequencing platform that allows the real-time analysis of deoxyribonucleic acid (DNA) or ribonucleic acid (RNA). This enables our customers to perform scientific/biomedical research in a range of areas, including human genetics, cancer research, outbreak surveillance, environmental analysis, pathogens/antimicrobial resistance, microbiome analysis, and crop science.

Oxford Nanopore Technologies (Oxford Nanopore Technologies) Headlines

From GuruFocus

Oxford Nanopore Announces Tech Updates

By ACCESSWIRE ACCESSWIRE 05-20-2022

ONT releases Remora: Most Comprehensive Methylation

By ACCESSWIRE ACCESSWIRE 05-26-2022

Fastest Human Genome Sequence Uses Oxford Nanopore

By ACCESSWIRE ACCESSWIRE 01-13-2022

Oxford Nanopore Releases Short Fragment Mode

By ACCESSWIRE ACCESSWIRE 03-23-2022

Genomics England Expands Nanopore Use in Cancer

By ACCESSWIRE ACCESSWIRE 04-04-2022

Oxford Nanopore Announces Technology Updates

By ACCESSWIRE ACCESSWIRE 12-02-2021

ONT Shows New High-Accuracy, High-Output Chemistry

By ACCESSWIRE ACCESSWIRE 03-30-2022